Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Tough Q1 In US For Glenmark, Eyes on Ryaltris Debut, Flovent Rival Filing
Teva Believed To Be Sole Other Flovent ANDA Filer
Aug 24 2022
•
By
Anju Ghangurde
Glenmark readies launches amid challenging US environment • Source: Shutterstock
More from Business
More from Generics Bulletin